DR. BEN BARLOW, Chief Medical Officer of Experity, has identified opportunities to leverage the power of technology in the complex urgent care environment, which requires a wide range of services. To overcome the challenges of long wait times and staffing shortages, Experity is streamlining workflows and making urgent care more efficient and patient-centered. Online scheduling, pre-visit information gathering, and access to existing electronic health records aid clinicians in treatment decisions and post-visit follow-up, resulting in improved delivery of on-demand healthcare services. Ben explains, "We do a lot of different things. I don't think people know what we do in urgent care. We started being an alternative for patients to the emergency department, but now we've evolved into being patient-centered to where the doctor waits on the patient. And so, that's what we do in urgent care. We take care of a lot of different needs of the patients, really dictated on what the patients want us to help them with." "I think that urgent care's strength is that we continue to think about the challenges the patients are experiencing and try to adapt to those challenges. An example is recently, when COVID hit, no one wanted to wait in lobbies. They didn't want to interact with other sick people. So urgent care ramped up its online scheduling, allowing patients to get on a waitlist online and then get texted when it was their time to come in. And so it's those kinds of things that, as challenges arise, the urgent care community is looking to address. Our major challenge right now is looking at the payer system, challenges with reimbursement, labor shortages, and things like that." "We want to think of the patient as not just the interaction that occurs inside the clinic but also before and after because the medical community and the healthcare environment are very complicated to navigate. We feel like urgent care is the front door into the system, so we're continuing to make products and services that help our clients help patients navigate the complexities of the healthcare environment." #Experity #UrgentCare #PatientExperience #Healthcare EXPERITYHEALTH.COM LISTEN TO THE PODCAST HERE http://experityhealth.com

1s

Mar 28

DR. BEN BARLOW, Chief Medical Officer of Experity, has identified opportunities to leverage the power of technology in the complex urgent care environment, which requires a wide range of services. To overcome the challenges of long wait times and staffing shortages, Experity is streamlining workflows and making urgent care more efficient and patient-centered. Online scheduling, pre-visit information gathering, and access to existing electronic health records aid clinicians in treatment decisions and post-visit follow-up, resulting in improved delivery of on-demand healthcare services. Ben explains, "We do a lot of different things. I don't think people know what we do in urgent care. We started being an alternative for patients to the emergency department, but now we've evolved into being patient-centered to where the doctor waits on the patient. And so, that's what we do in urgent care. We take care of a lot of different needs of the patients, really dictated on what the patients want us to help them with." "I think that urgent care's strength is that we continue to think about the challenges the patients are experiencing and try to adapt to those challenges. An example is recently, when COVID hit, no one wanted to wait in lobbies. They didn't want to interact with other sick people. So urgent care ramped up its online scheduling, allowing patients to get on a waitlist online and then get texted when it was their time to come in. And so it's those kinds of things that, as challenges arise, the urgent care community is looking to address. Our major challenge right now is looking at the payer system, challenges with reimbursement, labor shortages, and things like that." "We want to think of the patient as not just the interaction that occurs inside the clinic but also before and after because the medical community and the healthcare environment are very complicated to navigate. We feel like urgent care is the front door into the system, so we're continuing to make products and services that help our clients help patients navigate the complexities of the healthcare environment." #Experity #UrgentCare #PatientExperience #Healthcare EXPERITYHEALTH.COM DOWNLOAD THE TRANSCRIPT HERE http://experityhealth.com

18m

Mar 28

MEG BOEHME, living with multiple sclerosis and a friend, discusses her reaction to receiving the diagnosis of MS, which she had suspected for many years due to little-understood symptoms. Meg highlights the importance of doctors being aware of the early indications of MS and helping patients see this as a chronic condition that can, in part, be treated with lifestyle changes and staying active. She also emphasizes the need for more affordable access to the latest treatments.  Meg explains, "Oh, yes. It is a chronic condition. What annoys me is that in the media, it's often treated as a fatal condition. And for most of us, for those who don't have the progressive form, it fortunately is not. It doesn't have to be. The diagnosis is not necessarily the end of the world." "There are good treatments coming down the road. The key to it is keeping yourself active and keeping your own body as healthy as you can. Eating well, staying active, keeping your weight manageable, keeping your diet manageable. Don't do stupid things. That being responsible for your own body, being responsible for your own life. When you get a diagnosis of anything like this, you need to take a look and know that you need to take care of yourself." "It's a lifesaver, quite literally. I'll go into the chorus in pain, and the pain disappears. Singing is, in all ways, the lifeblood of me. And yes, the singing, the breathing, the posture, the fact that I stand on the risers for three hours a week, that it keeps my brain active, that I have to learn the music. We sing completely acapella. We have about three weeks to learn a piece of music and then sing without looking at the music. And that my director has MS and is not sympathetic towards me. If I'm dizzy or have a problem, I can sit, but I mostly don't. I gut it out. But if I come in pain, most of the time, I don't leave in pain. It's just the thing that keeps me going, and I think the big thing is that it keeps my brain active." #MS #MultipleSclerosis #ChronicDiseases LISTEN TO THE PODCAST HERE img

1s

Mar 27

MEG BOEHME, living with multiple sclerosis and a friend, discusses her reaction to receiving the diagnosis of MS, which she had suspected for many years due to little-understood symptoms. Meg highlights the importance of doctors being aware of the early indications of MS and helping patients see this as a chronic condition that can, in part, be treated with lifestyle changes and staying active. She also emphasizes the need for more affordable access to the latest treatments.  Meg explains, "Oh, yes. It is a chronic condition. What annoys me is that in the media, it's often treated as a fatal condition. And for most of us, for those who don't have the progressive form, it fortunately is not. It doesn't have to be. The diagnosis is not necessarily the end of the world." "There are good treatments coming down the road. The key to it is keeping yourself active and keeping your own body as healthy as you can. Eating well, staying active, keeping your weight manageable, keeping your diet manageable. Don't do stupid things. That being responsible for your own body, being responsible for your own life. When you get a diagnosis of anything like this, you need to take a look and know that you need to take care of yourself." "It's a lifesaver, quite literally. I'll go into the chorus in pain, and the pain disappears. Singing is, in all ways, the lifeblood of me. And yes, the singing, the breathing, the posture, the fact that I stand on the risers for three hours a week, that it keeps my brain active, that I have to learn the music. We sing completely acapella. We have about three weeks to learn a piece of music and then sing without looking at the music. And that my director has MS and is not sympathetic towards me. If I'm dizzy or have a problem, I can sit, but I mostly don't. I gut it out. But if I come in pain, most of the time, I don't leave in pain. It's just the thing that keeps me going, and I think the big thing is that it keeps my brain active." #MS #MultipleSclerosis #ChronicDiseases DOWNLOAD THE TRANSCRIPT HERE img

17m

Mar 27

KINSEY FABRIZIO, now President of the Consumer Technology Association,  highlights many digital health innovations in the women's health arena showcased in the recent CES 2024 event.  A recent CTA study found that 45% of women currently use digital health solutions, and 75% of women in the survey face challenges obtaining healthcare services. With oversight from the FDA, medical devices and wearables are becoming increasingly accurate. With the addition of AI, they are expected to play a role in improving healthcare outcomes and access.   Kinsey explains, "CTA is a nonprofit trade association, and we represent the entire consumer technology industry. And a big part of that is digital health. We have members who are digital health companies, and we strive to help advance the industry for them. We do that through policy, research, and standards development. We're an ANSI-Accredited Standards organization, and through different events, we convene the industry together." "We saw a lot of really exciting innovations in women's health at the CES 2024 show. Digital health is always a really big category for CES. We have hundreds of exhibitors in this category, and we do two full days of conference programming called our Digital Health Summit. And it's an opportunity for the industry to come together and talk about the exciting transformation of healthcare led by technology. But some really exciting products that we saw in the women's health space were just unique and stood out." "That is just an example of how tech is starting to be tailored to address specific women's health issues. This isn't something I would've seen at CES 10 years ago, so it shows the evolution and advancement there. Another product that I thought was just game-changing is Cerviray, a cancer screening device by AIDOT, which utilizes a very specific technique called visual inspection with acetic acid. And it's faster, simpler, and less invasive than traditional tests like the pap smear." #CTA #ConsumerTechnologyAssociation #EmpowerHerHealth #AIforHerHealth #EmpowHERHealth #FutureofFeminineHealth CTA.TECH http://cta.tech LISTEN TO THE PODCAST HERE img

1s

Mar 26

KINSEY FABRIZIO, now President of the Consumer Technology Association,  highlights many digital health innovations in the women's health arena showcased in the recent CES 2024 event.  A recent CTA study found that 45% of women currently use digital health solutions, and 75% of women in the survey face challenges obtaining healthcare services. With oversight from the FDA, medical devices and wearables are becoming increasingly accurate. With the addition of AI, they are expected to play a role in improving healthcare outcomes and access.   Kinsey explains, "CTA is a nonprofit trade association, and we represent the entire consumer technology industry. And a big part of that is digital health. We have members who are digital health companies, and we strive to help advance the industry for them. We do that through policy, research, and standards development. We're an ANSI-Accredited Standards organization, and through different events, we convene the industry together." "We saw a lot of really exciting innovations in women's health at the CES 2024 show. Digital health is always a really big category for CES. We have hundreds of exhibitors in this category, and we do two full days of conference programming called our Digital Health Summit. And it's an opportunity for the industry to come together and talk about the exciting transformation of healthcare led by technology. But some really exciting products that we saw in the women's health space were just unique and stood out." "That is just an example of how tech is starting to be tailored to address specific women's health issues. This isn't something I would've seen at CES 10 years ago, so it shows the evolution and advancement there. Another product that I thought was just game-changing is Cerviray, a cancer screening device by AIDOT, which utilizes a very specific technique called visual inspection with acetic acid. And it's faster, simpler, and less invasive than traditional tests like the pap smear." #CTA #ConsumerTechnologyAssociation #EmpowerHerHealth #AIforHerHealth #EmpowHERHealth #FutureofFeminineHealth CTA.TECH http://cta.tech DOWNLOAD THE TRANSCRIPT HERE img

18m

Mar 26

DAHLIA ATTIA-KING, CEO of Panacea, is bringing whole exome sequencing to a broader audience and promoting the value of this data for disease prevention and making smarter lifestyle choices. She highlights the differences between whole exome sequencing and whole genome sequencing, noting that whole exome sequencing can be conducted more cost-effectively and provide information about the genes most likely to impact health.   Dahlia explains, "These two barriers, the physicians and the insurers, are sometimes big barriers to accessing clinical genetic testing for people, even those who need it and those who fit the current guidelines. We aim to bypass those barriers and partner with very skilled CLIA/CAP certified laboratories. We partner with trained clinical genetic counselors. We partner with physicians who understand how to utilize genetic testing, and we bring those services collectively in one very simple, user-friendly experience so that no one who wants genetic testing will struggle to get it." "We do that and focus on whole exome because, number one, it's more cost-effective. It's actually quite a lot more expensive to sequence the entire genome. So when you focus on just the genes, you focus on the 20,000 plus genes in the genome and nothing else. But that's so valuable because the vast majority of changes or mutations in your genome that affect your susceptibility for disease happen in the exome." "But to your point, there is also a large amount of data that can come off the exome that is interpretable. And in a lot of cases, just like you said, it's actionable, which means that information can be used to make certain targeted decisions in your healthcare so that you can essentially, in a way, get ahead of your genes or outsmart your genes because you're prepared. You know the instructions that your genes are holding and where your risks might be. That way, you can certainly better target your healthcare and take a more preventative approach as opposed to a reactionary approach, which happens in most cases in today's healthcare." #SeekPanacea #WholeExomeSequencing #WholeGenomeSequencing #Genome #PreventativeMedicine SEEKPANACEA.COM LISTEN TO THE PODCAST HERE img  

1s

Mar 20

DAHLIA ATTIA-KING, CEO of Panacea, is bringing whole exome sequencing to a broader audience and promoting the value of this data for disease prevention and making smarter lifestyle choices. She highlights the differences between whole exome sequencing and whole genome sequencing, noting that whole exome sequencing can be conducted more cost-effectively and provide information about the genes most likely to impact health.   Dahlia explains, "These two barriers, the physicians and the insurers, are sometimes big barriers to accessing clinical genetic testing for people, even those who need it and those who fit the current guidelines. We aim to bypass those barriers and partner with very skilled CLIA/CAP certified laboratories. We partner with trained clinical genetic counselors. We partner with physicians who understand how to utilize genetic testing, and we bring those services collectively in one very simple, user-friendly experience so that no one who wants genetic testing will struggle to get it." "We do that and focus on whole exome because, number one, it's more cost-effective. It's actually quite a lot more expensive to sequence the entire genome. So when you focus on just the genes, you focus on the 20,000 plus genes in the genome and nothing else. But that's so valuable because the vast majority of changes or mutations in your genome that affect your susceptibility for disease happen in the exome." "But to your point, there is also a large amount of data that can come off the exome that is interpretable. And in a lot of cases, just like you said, it's actionable, which means that information can be used to make certain targeted decisions in your healthcare so that you can essentially, in a way, get ahead of your genes or outsmart your genes because you're prepared. You know the instructions that your genes are holding and where your risks might be. That way, you can certainly better target your healthcare and take a more preventative approach as opposed to a reactionary approach, which happens in most cases in today's healthcare." #SeekPanacea #WholeExomeSequencing #WholeGenomeSequencing #Genome #PreventativeMedicine SEEKPANACEA.COM DOWNLOAD THE TRANSCRIPT HERE img  

20m

Mar 20

STEVEN LEE, Co-Founder and CEO of Ianacare, is in the business of supporting caregivers by working with employers, health plans, and providers to offer services that patients and their families need. Effective hospital-at-home and home non-clinical care models show a reduction in hospital readmission and cost of care. This care navigator approach allows caregivers to keep patients in their homes and reduces employee absenteeism. Working with partners, Ianacare has applied to be an approved provider in the new CMS program GUIDE, the Guiding and Improved Dementia Experience program, to expand the application of this model. Steven explains, "This has become really critical. For one reason, good caregiving in the home keeps patients in the home and out of institutions. And that's a win-win-win for everybody. Patients prefer being in the familiar surroundings of their home. We all would prefer to age in our own homes. It's cheaper for the healthcare system. Every inpatient admission or ER visit prevented by a family care member is thousands of dollars saved in the healthcare system."   "So it's really a win-win-win. The numbers and the research out there clearly prove these caregivers' critical role. I'll cite a couple of studies. There's a UPMC study that shows when family caregivers are involved and engaged in care plans, hospital readmissions decrease by 25%. Conversely, there's a study from the Journal of American Geriatric Society when patients have caregivers who are depressed, burnt out, or tired, they experienced a 73% increase in ED utilization and $2,000 higher medical costs over six months. So, to summarize, good caregiving keeps patients in the home, and that's why this is important."   "What we've done is bring together all the layers of resources you might need at some point in the care journey into one easy-to-use experience. We have a platform accessible through a browser or smartphone, and it starts by matching you up with unlimited access to a care navigator who's your right-hand expert to not only guide you through decisions and planning but also ensure things get done." #Ianacare #Caregivers #HospitalatHome #HospitalReadmission #CareNavigators #CMSGUIDE #AlzheimersDisease IANACARE.COM LISTEN TO THE PODCAST HERE http://Ianacare.com

1s

Mar 19

STEVEN LEE, Co-Founder and CEO of Ianacare, is in the business of supporting caregivers by working with employers, health plans, and providers to offer services that patients and their families need. Effective hospital-at-home and home non-clinical care models show a reduction in hospital readmission and cost of care. This care navigator approach allows caregivers to keep patients in their homes and reduces employee absenteeism. Working with partners, Ianacare has applied to be an approved provider in the new CMS program GUIDE, the Guiding and Improved Dementia Experience program, to expand the application of this model. Steven explains, "This has become really critical. For one reason, good caregiving in the home keeps patients in the home and out of institutions. And that's a win-win-win for everybody. Patients prefer being in the familiar surroundings of their home. We all would prefer to age in our own homes. It's cheaper for the healthcare system. Every inpatient admission or ER visit prevented by a family care member is thousands of dollars saved in the healthcare system."   "So it's really a win-win-win. The numbers and the research out there clearly prove these caregivers' critical role. I'll cite a couple of studies. There's a UPMC study that shows when family caregivers are involved and engaged in care plans, hospital readmissions decrease by 25%. Conversely, there's a study from the Journal of American Geriatric Society when patients have caregivers who are depressed, burnt out, or tired, they experienced a 73% increase in ED utilization and $2,000 higher medical costs over six months. So, to summarize, good caregiving keeps patients in the home, and that's why this is important."   "What we've done is bring together all the layers of resources you might need at some point in the care journey into one easy-to-use experience. We have a platform accessible through a browser or smartphone, and it starts by matching you up with unlimited access to a care navigator who's your right-hand expert to not only guide you through decisions and planning but also ensure things get done." #Ianacare #Caregivers #HospitalatHome #HospitalReadmission #CareNavigators #CMSGUIDE #AlzheimersDisease IANACARE.COM DOWNLOAD THE TRANSCRIPT HERE http://Ianacare.com

19m

Mar 19

STELLA VNOOK, the Founder and President, and BILL BREITENBACH, CEO of Oral Bio Life, talk about the prevalence and causes of periodontal disease and the limitations of current treatments. The Oral Bio Life PiezoGEL technology has shown effective removal of plaque and treatment of bacteria on teeth and regenerating bone for a long-term solution. Periodontal disease contributes to inflammation and infection and is showing links to other health conditions like cancer, heart disease, diabetes, and Alzheimer's disease. In addition to human trials, success is seen in trials with veterinarians to regenerate bone in dogs.  Stella Vnook elaborates, "Dentists can identify the early warning signs, but in addition to oral hygiene, we also found, and it's supported by data, there are some people who are predisposed to just having issues with their gums and/or periodontal disease. There are genetic implications, and there are people that have comorbidities. The goal is to remove the plaque and the bacteria film. But the process is rather painful. One of the reasons why I founded this technology and this company is because of the scaling and root planing, which is quite painful." Bill explains, "I'd like to add there's a real recognition lately from scientists around the world that inflammation is the root cause of a lot of major diseases - cancer, heart disease, diabetes, and even Alzheimer's. What they're finding is that the fibrous bacteria travel from the mouth throughout the body, contributing to heart disease, diabetes, pregnancy complications, cancer, and Alzheimer's. Just recently, there's some NIH data that shows that P. gingivitis, the main pathogen for chronic gum disease, has been identified in the brain of Alzheimer's disease patients. So, it's not just about gum disease, it's about total body health, and there is a need to be taking care of that and being mindful of the downstream effects of not taking care of periodontal disease." #OralBioLife #GumDisease #PeriodontalDisease #Inflammation #Veterinarians #BoneRegeneration ORALBIOLIFE.COM http://oralbiolife.com LISTEN TO THE PODCAST HERE img http://oralbiolife.com

1s

Mar 18

STELLA VNOOK, the Founder and President, and BILL BREITENBACH, CEO of Oral Bio Life, talk about the prevalence and causes of periodontal disease and the limitations of current treatments. The Oral Bio Life PiezoGEL technology has shown effective removal of plaque and treatment of bacteria on teeth and regenerating bone for a long-term solution. Periodontal disease contributes to inflammation and infection and is showing links to other health conditions like cancer, heart disease, diabetes, and Alzheimer's disease. In addition to human trials, success is seen in trials with veterinarians to regenerate bone in dogs.  Stella Vnook elaborates, "Dentists can identify the early warning signs, but in addition to oral hygiene, we also found, and it's supported by data, there are some people who are predisposed to just having issues with their gums and/or periodontal disease. There are genetic implications, and there are people that have comorbidities. The goal is to remove the plaque and the bacteria film. But the process is rather painful. One of the reasons why I founded this technology and this company is because of the scaling and root planing, which is quite painful." Bill explains, "I'd like to add there's a real recognition lately from scientists around the world that inflammation is the root cause of a lot of major diseases - cancer, heart disease, diabetes, and even Alzheimer's. What they're finding is that the fibrous bacteria travel from the mouth throughout the body, contributing to heart disease, diabetes, pregnancy complications, cancer, and Alzheimer's. Just recently, there's some NIH data that shows that P. gingivitis, the main pathogen for chronic gum disease, has been identified in the brain of Alzheimer's disease patients. So, it's not just about gum disease, it's about total body health, and there is a need to be taking care of that and being mindful of the downstream effects of not taking care of periodontal disease." #OralBioLife #GumDisease #PeriodontalDisease #Inflammation #Veterinarians #BoneRegeneration ORALBIOLIFE.COM http://oralbiolife.com DOWNLOAD THE TRANSCRIPT HERE img http://oralbiolife.com

22m

Mar 18

CHUCK RINKER, CEO of PRSONAS, sees the next-generation workforce of digital healthcare components as digital personalities and avatars that will act as patient advocates and improve the communications between patients and clinicians. With an emphasis on building trust and showing empathy, these digital tools help gather accurate information and break down language and cultural barriers. Avatars can be customized for locations like hospital lobbies and purposes like clinical trial recruitment. With a background in game programming, Chuck brings a deep knowledge of how the emotional bond between gamers and avatars can be applied to building more robust patient engagement. Chuck explains, "Since technology has been predominant in the healthcare space, we've always had to teach people how to use technology, and the barrier is communication. So, we've said, well, let's just take a different approach. We're not trying to recreate humans, and we're not trying to replace humans. We're just trying to teach all this technology, this scalable healthcare, this improvement in healthcare technology that we have, and make it so that it can communicate to us as humans. We naturally communicate as humans. We don't naturally communicate as an IT specialist, so we're trying to flip it on its head and work it the other way around." "That was a concept we started way back in 2013. We originally built a few of these as product specialists in the pharmaceutical drug launch space. I think Genentech and Pfizer were probably the first ones to use it. It was meant to support the healthcare professionals. Okay, what's all the information you have, from prescribing information to all the complexities of a mechanism of disease and all that you have to relay over and over and over during a multiphase pharmaceutical launch? So, we built these repeatable humans to be those domain experts." "We've learned along the way that it was a great, wonderful piece but that the patients themselves are the ones who are getting "lost in the mix." So, our units are trained to speak whatever language is used by the patient population you're targeting. They can be culturally diverse. We do Sign Language - American Sign Language and British Sign Language. So it's really about creating that advocate, breaking down that communication barrier so that every patient feels represented and welcomed and has their own patient advocate to help them through that healthcare journey."  #PRSONAS #Avatars #DigitalPersonalities #DigitalHealth #AI #PatientAdvocate #PatientEngagement #ClinicalTrials  PRSONAS.COM LISTEN TO THE PODCAST HERE    http://PRSONAS.com

1s

Mar 14

CHUCK RINKER, CEO of PRSONAS, sees the next-generation workforce of digital healthcare components as digital personalities and avatars that will act as patient advocates and improve the communications between patients and clinicians. With an emphasis on building trust and showing empathy, these digital tools help gather accurate information and break down language and cultural barriers. Avatars can be customized for locations like hospital lobbies and purposes like clinical trial recruitment. With a background in game programming, Chuck brings a deep knowledge of how the emotional bond between gamers and avatars can be applied to building more robust patient engagement. Chuck explains, "Since technology has been predominant in the healthcare space, we've always had to teach people how to use technology, and the barrier is communication. So, we've said, well, let's just take a different approach. We're not trying to recreate humans, and we're not trying to replace humans. We're just trying to teach all this technology, this scalable healthcare, this improvement in healthcare technology that we have, and make it so that it can communicate to us as humans. We naturally communicate as humans. We don't naturally communicate as an IT specialist, so we're trying to flip it on its head and work it the other way around." "That was a concept we started way back in 2013. We originally built a few of these as product specialists in the pharmaceutical drug launch space. I think Genentech and Pfizer were probably the first ones to use it. It was meant to support the healthcare professionals. Okay, what's all the information you have, from prescribing information to all the complexities of a mechanism of disease and all that you have to relay over and over and over during a multiphase pharmaceutical launch? So, we built these repeatable humans to be those domain experts." "We've learned along the way that it was a great, wonderful piece but that the patients themselves are the ones who are getting "lost in the mix." So, our units are trained to speak whatever language is used by the patient population you're targeting. They can be culturally diverse. We do Sign Language - American Sign Language and British Sign Language. So it's really about creating that advocate, breaking down that communication barrier so that every patient feels represented and welcomed and has their own patient advocate to help them through that healthcare journey."  #PRSONAS #Avatars #DigitalPersonalities #DigitalHealth #AI #PatientAdvocate #PatientEngagement #ClinicalTrials  PRSONAS.COM DOWNLOAD THE TRANSCRIPT HERE    http://PRSONAS.com

18m

Mar 14

CODY SHANDRAW, President and Co-Founder of Healing Realty Trust, aims to provide robust mental and behavioral health treatment facilities. The lack of infrastructure has been a significant hurdle for expanding the commercialization of drugs that require longer in-office visits and space to accommodate the needs of patients undergoing treatments. The emerging field of psychedelics for treating neurological conditions like PTSD requires clinicians to understand the physical requirements for treatment facilities to provide privacy and comfort during the extended time necessary for many of these treatments.  Cody explains, "In 2020, it was a really interesting stat that I was made aware of at one of the conferences down here in Miami. It was around a drug called Spravato, which is an intranasal ketamine drug. And they were very excited about the launch. It was in development for quite some time, and unfortunately, it didn't commercialize, I think, to their expectations. I asked one of the drug reps down here in Florida why he thought that was, and he said it was a really simple answer: the lack of infrastructure." "It's a unique drug, and we've only seen this a couple of times. Maybe proton therapy or dialysis centers where when a new therapy is approved, you need that infrastructure to go along with that therapy. And that is what Spravato was. You actually had to be in a clinic for two hours after administration for Spravato. So it was a very unique thing. And a lot of the legacy behavioral mental health providers that would be the target market for that drug, they didn't want to disrupt normal patient inflows into their clinic. So it took a couple of years. When that drug was launched, there were less than a hundred clinics in the United States offering that. Today, there are 2,700 of those clinics, and now Spravato is a blockbuster drug." #HealingRealtyTrust #CommercialRealEstate #BehavioralHealth #EmergingTherapies #PsychedelicAssistedTherapy #PatientAccess #HealthcareInfrastructure #ImprovingBehavioralHealth HEALINGRT.COM http://HealingRT.com LISTEN TO THE PODCAST HERE img http://HealingRT.com

1s

Mar 13

CODY SHANDRAW, President and Co-Founder of Healing Realty Trust, aims to provide robust mental and behavioral health treatment facilities. The lack of infrastructure has been a significant hurdle for expanding the commercialization of drugs that require longer in-office visits and space to accommodate the needs of patients undergoing treatments. The emerging field of psychedelics for treating neurological conditions like PTSD requires clinicians to understand the physical requirements for treatment facilities to provide privacy and comfort during the extended time necessary for many of these treatments.  Cody explains, "In 2020, it was a really interesting stat that I was made aware of at one of the conferences down here in Miami. It was around a drug called Spravato, which is an intranasal ketamine drug. And they were very excited about the launch. It was in development for quite some time, and unfortunately, it didn't commercialize, I think, to their expectations. I asked one of the drug reps down here in Florida why he thought that was, and he said it was a really simple answer: the lack of infrastructure." "It's a unique drug, and we've only seen this a couple of times. Maybe proton therapy or dialysis centers where when a new therapy is approved, you need that infrastructure to go along with that therapy. And that is what Spravato was. You actually had to be in a clinic for two hours after administration for Spravato. So it was a very unique thing. And a lot of the legacy behavioral mental health providers that would be the target market for that drug, they didn't want to disrupt normal patient inflows into their clinic. So it took a couple of years. When that drug was launched, there were less than a hundred clinics in the United States offering that. Today, there are 2,700 of those clinics, and now Spravato is a blockbuster drug." #HealingRealtyTrust #CommercialRealEstate #BehavioralHealth #EmergingTherapies #PsychedelicAssistedTherapy #PatientAccess #HealthcareInfrastructure #ImprovingBehavioralHealth HEALINGRT.COM http://HealingRT.com DOWNLOAD THE TRANSCRIPT HERE img http://HealingRT.com

18m

Mar 13

FENGRU LIN, Co-Founder and CEO of TurtleTree, is applying precision fermentation technology to produce high-value ingredients for food and beverages without the need for animals. This biotech company's first goal is to expand the production of lactoferrin, a protein found in small quantities in milk that has been shown to promote gut health and immunity. Finding a scalable way to produce lactoferrin will lead to adding this iron-binding element to plant-based milks and energy drinks.   Fengru explains, "A couple of years ago, I was learning how to make cheese as a hobby. It was quite a fanatic period of time. I went up to Vermont from Singapore for a couple of weeks to learn how to make cheese and I wanted to replicate this whole process back in Singapore. But in Singapore, we have no access to cows, we have no access to raw, fresh milk. So, I had to go down to Indonesia and Thailand to look for milk. In this journey, I was exposed to a lot of challenges around the dairy industry, things like contract farming, things like antibiotics, and hormones being pumped into the cows. As a result, the milk quality always suffers, the mozzarella couldn't stretch, it's not enough calcium, not enough nutrients in the milk. So, I gave up that whole idea and was still working for Google."   "So, we bootstrapped initially, brought in some scientists, did a lot of research, and filed our first patent. The technology requires getting memory cells and culturing the cells to express full-function milk, all 2,000 different ingredients in milk. We had our early success and quickly brought this technology to some of the biggest dairy companies in the world, folks like Fonterra and Abbott, and told them, "Hey, we can make milk. What do you think?" "Very quickly they came back with feedback saying, "Well, great that you can make milk, but milk is $2 a gallon. I don't think you can get to the price point anytime soon. You should really be focused on high-value ingredients that are found in milk." So they gave us a list of half a dozen proteins and ingredients that we should look at, and at the top of the list is lactoferrin because of all these great benefits and the high price point it is today. You guys should be focused on the high-value ingredients that are low in supply across the market so you can address this accessibility problem and not try to reproduce a commodity like milk. So that's how we started and where we are today. We just got our FDA Self GRAS status in November last year, so we've started to commercialize this lactoferrin." #TurtleTree #FunctionalFood #Lactoferrin #Protein #PrecisionFermentation #Milk #SustainableFoodProduction #Nutrition TURTLETREE.COM http://turtletree.com LISTEN TO THE PODCAST HERE img http://turtletree.com

1s

Mar 12

FENGRU LIN, Co-Founder and CEO of TurtleTree, is applying precision fermentation technology to produce high-value ingredients for food and beverages without the need for animals. This biotech company's first goal is to expand the production of lactoferrin, a protein found in small quantities in milk that has been shown to promote gut health and immunity. Finding a scalable way to produce lactoferrin will lead to adding this iron-binding element to plant-based milks and energy drinks.   Fengru explains, "A couple of years ago, I was learning how to make cheese as a hobby. It was quite a fanatic period of time. I went up to Vermont from Singapore for a couple of weeks to learn how to make cheese and I wanted to replicate this whole process back in Singapore. But in Singapore, we have no access to cows, we have no access to raw, fresh milk. So, I had to go down to Indonesia and Thailand to look for milk. In this journey, I was exposed to a lot of challenges around the dairy industry, things like contract farming, things like antibiotics, and hormones being pumped into the cows. As a result, the milk quality always suffers, the mozzarella couldn't stretch, it's not enough calcium, not enough nutrients in the milk. So, I gave up that whole idea and was still working for Google."   "So, we bootstrapped initially, brought in some scientists, did a lot of research, and filed our first patent. The technology requires getting memory cells and culturing the cells to express full-function milk, all 2,000 different ingredients in milk. We had our early success and quickly brought this technology to some of the biggest dairy companies in the world, folks like Fonterra and Abbott, and told them, "Hey, we can make milk. What do you think?" "Very quickly they came back with feedback saying, "Well, great that you can make milk, but milk is $2 a gallon. I don't think you can get to the price point anytime soon. You should really be focused on high-value ingredients that are found in milk." So they gave us a list of half a dozen proteins and ingredients that we should look at, and at the top of the list is lactoferrin because of all these great benefits and the high price point it is today. You guys should be focused on the high-value ingredients that are low in supply across the market so you can address this accessibility problem and not try to reproduce a commodity like milk. So that's how we started and where we are today. We just got our FDA Self GRAS status in November last year, so we've started to commercialize this lactoferrin." #TurtleTree #FunctionalFood #Lactoferrin #Protein #PrecisionFermentation #Milk #SustainableFoodProduction #Nutrition TURTLETREE.COM http://turtletree.com DOWNLOAD THE TRANSCRIPT HERE img http://turtletree.com

18m

Mar 12

CHRISTIAN LILLIS, Co-Founder and CEO of the Peggy Lillis Foundation is a patient advocate in the fight against C. diff infection. Clostridium difficile is an opportunistic infection of the gut that often occurs after taking antibiotics and can lead to life-threatening complications. Christian shares his personal story of losing his mother to C. diff and highlights the progress made in raising awareness and the development of new treatments for the infection. The Peggy Lillis Foundation emphasizes the importance of patient voices in shaping infectious disease policies and research and the need for community support to fight C. diff and other preventable infectious diseases. Christian explains, "Last time we did our most recent C. diff awareness month campaign in November, it was our most successful one yet. We reached around 23 million people through a mix of earned, print, video, and podcast media and a strong social media campaign. We also had it bolstered by media partnerships with Contagion Live and Pharmacy Times. As part of our programming for the month, we held a virtual town hall, and about 200 people attended. More than half of them were C. diff patients, survivors, and family members." "Other progress was at the end of 2022, and then in early 2023, two new therapies. Technically, they are classified as preventative by the FDA, but they are basically microbiome restoration therapies. As I said earlier, when you take antibiotics, there can be other causes. Still, when your gut microbiome, gut bacteria, and viruses get out of whack or depleted, you become very vulnerable to C. diff. And a reason why people struggle to get over C. diff is because their gut microbiome remains degraded. So these new two therapies, one is done by enema, one is given by capsule over several days, it's a really huge change for people who are battling recurrent C. diff."  #CDiff #PeggyLillisFoundation #ClostridiumDifficile #CDifficile #PatientAdvocacy #CdiffAwarenessMonth CDIFF.ORG http://cdiff.org LISTEN TO THE PODCAST HERE http://cdiff.org

1s

Mar 11

CHRISTIAN LILLIS, Co-Founder and CEO of the Peggy Lillis Foundation is a patient advocate in the fight against C. diff infection. Clostridium difficile is an opportunistic infection of the gut that often occurs after taking antibiotics and can lead to life-threatening complications. Christian shares his personal story of losing his mother to C. diff and highlights the progress made in raising awareness and the development of new treatments for the infection. The Peggy Lillis Foundation emphasizes the importance of patient voices in shaping infectious disease policies and research and the need for community support to fight C. diff and other preventable infectious diseases. Christian explains, "Last time we did our most recent C. diff awareness month campaign in November, it was our most successful one yet. We reached around 23 million people through a mix of earned, print, video, and podcast media and a strong social media campaign. We also had it bolstered by media partnerships with Contagion Live and Pharmacy Times. As part of our programming for the month, we held a virtual town hall, and about 200 people attended. More than half of them were C. diff patients, survivors, and family members." "Other progress was at the end of 2022, and then in early 2023, two new therapies. Technically, they are classified as preventative by the FDA, but they are basically microbiome restoration therapies. As I said earlier, when you take antibiotics, there can be other causes. Still, when your gut microbiome, gut bacteria, and viruses get out of whack or depleted, you become very vulnerable to C. diff. And a reason why people struggle to get over C. diff is because their gut microbiome remains degraded. So these new two therapies, one is done by enema, one is given by capsule over several days, it's a really huge change for people who are battling recurrent C. diff."  #CDiff #PeggyLillisFoundation #ClostridiumDifficile #CDifficile #PatientAdvocacy #CdiffAwarenessMonth CDIFF.ORG http://cdiff.org DOWNLOAD THE TRANSCRIPT HERE http://cdiff.org

21m

Mar 11

PAUL HICKEY, President and CEO of ReShape Lifesciences, discusses the company's role in the weight loss industry. The ReShape Lap-Band® and the new ReShape Lap-Band® 2.0 FLEX are tested surgical options for weight loss and weight management and are now being joined in the market by GLP-1 agonists such as Wegovy and Ozempic. While these options are effective for different individuals, Paul emphasizes the importance of a comprehensive approach that includes diet and lifestyle changes. As a society, we have normalized obesity, and more education is needed to inform those with obesity about these effective solutions.  Paul explains, "The weight loss drugs people have been hearing about are the first step for weight loss, along with working with your physician and their team. And then as you move down, the more aggressive treatment, the ReShape products, and in particular the Lap-Band®, which has been around for over 20 years, is the first surgical step performed by a laparoscopic surgeon that goes in and helps to provide for a way to get back on the weight loss path for individuals. And then, beyond that, you have other procedures that are more aggressive that people also have to consider as they continue their journey." "We see physicians today using the GLP-1s as combination therapy for someone who has a Lap-Band® or a gastric sleeve or a gastric bypass who may have had any one of those procedures, including a Lap-Band® for five or ten years and started to plateau or reverse on their weight loss. Those GLP-1s can be administered and prescribed for those who want to get back on the path to weight loss." "There are a lot of differences in the type of obesity that someone has. There are a lot of differences in what treatments work better or worse for individuals. I think the side effect, part of the answer to the question is with the GLP-1s, there's going to be probably more studies to come out to show what side effects the GLP-1s have on different population sets. It is certainly being studied today, and the data out there now is part of the data used to get the drugs approved." #ReShapeLifesciences #LapBandLife #ReShapeLapBand #LapBand #LapBandFLEX #WeightLoss #GLP1 RESHAPELIFESCIENCES.COM http://reshapelifesciences.com LISTEN TO THE PODCAST HERE

1s

Mar 06

PAUL HICKEY, President and CEO of ReShape Lifesciences, discusses the company's role in the weight loss industry. The ReShape Lap-Band® and the new ReShape Lap-Band® 2.0 FLEX are tested surgical options for weight loss and weight management and are now being joined in the market by GLP-1 agonists such as Wegovy and Ozempic. While these options are effective for different individuals, Paul emphasizes the importance of a comprehensive approach that includes diet and lifestyle changes. As a society, we have normalized obesity, and more education is needed to inform those with obesity about these effective solutions.  Paul explains, "The weight loss drugs people have been hearing about are the first step for weight loss, along with working with your physician and their team. And then as you move down, the more aggressive treatment, the ReShape products, and in particular the Lap-Band®, which has been around for over 20 years, is the first surgical step performed by a laparoscopic surgeon that goes in and helps to provide for a way to get back on the weight loss path for individuals. And then, beyond that, you have other procedures that are more aggressive that people also have to consider as they continue their journey." "We see physicians today using the GLP-1s as combination therapy for someone who has a Lap-Band® or a gastric sleeve or a gastric bypass who may have had any one of those procedures, including a Lap-Band® for five or ten years and started to plateau or reverse on their weight loss. Those GLP-1s can be administered and prescribed for those who want to get back on the path to weight loss." "There are a lot of differences in the type of obesity that someone has. There are a lot of differences in what treatments work better or worse for individuals. I think the side effect, part of the answer to the question is with the GLP-1s, there's going to be probably more studies to come out to show what side effects the GLP-1s have on different population sets. It is certainly being studied today, and the data out there now is part of the data used to get the drugs approved." #ReShapeLifesciences #LapBandLife #ReShapeLapBand #LapBand #LapBandFLEX #WeightLoss #GLP1 RESHAPELIFESCIENCES.COM http://reshapelifesciences.com DOWNLOAD THE TRANSCRIPT HERE

18m

Mar 06

MATT HOLLINGSWORTH, Co-Founder of Carta Healthcare, has identified the need to change how hospitals complete clinical registries, which require information from clinical notes. Currently, nurses manually fill out the forms primarily based on their understanding of the notes from the doctors. Using AI to read through notes, extract relevant information, and enter the data into the clinical registry form saves nurses 95% of their time, improves accuracy, and highlights actionable data. This approach allows the abstractors to spend more time on complex cases and uncover overlooked medical conditions. Matt explains, "What we do is collect data for these things called clinical registries, which are required quality submissions that hospitals have to do. And we bring AI to the table so that we can make it a not-so-manual process. Historically, the way these forms have been completed has been with just nurse time. Also, I don't think there's a word in the English language to quite correctly describe form in this particular scenario. Just to give a concrete example, if a PCI, so a stent installation via cath is performed, it takes a nurse about an hour and a half to fill out the documentation required to do the submission to the registry. It takes a really long time." "The problem is that most of it is in the notes. So one of the questions in a registry was the patient hypertensive upon admission. And the way you figure that out is you look, in most cases, in the H&P note and read through it. It'll say somewhere in there that there's either a history of hypertension or they took a blood pressure, and now they have it, etc. And so, the nurse, to paint a picture about what this looks like here, what the nurse is doing is they have the EHR open on one screen, a form to fill out on the other, and they're reading through notes, reaching conclusions, and then filling out the form. So, most of the data needed for this whole process is in the clinical notes, not in some structured form." "Yes, so this is how we define quality in the whole shift to value-based care. A necessary component is that you measure quality in it. And this is just how the sausage is made for doing that. The way you measure something is you collect data for it. These registries are there to collect data, and in many cases, they are procedure-based. Sometimes, it's condition-based, like there's a COVID registry or what have you. Sometimes, it's a location-based thing like this patient was admitted to this unit like a CVICU or an acute care floor."  #CartaHealth #GenAI #HealthSystems #2024MedicalPredictions #HealthTech #MedTech CARTA.HEALTHCARE http://Carta.Healthcare LISTEN TO THE PODCAST HERE http://Carta.Healthcare

1s

Mar 05

MATT HOLLINGSWORTH, Co-Founder of Carta Healthcare, has identified the need to change how hospitals complete clinical registries, which require information from clinical notes. Currently, nurses manually fill out the forms primarily based on their understanding of the notes from the doctors. Using AI to read through notes, extract relevant information, and enter the data into the clinical registry form saves nurses 95% of their time, improves accuracy, and highlights actionable data. This approach allows the abstractors to spend more time on complex cases and uncover overlooked medical conditions. Matt explains, "What we do is collect data for these things called clinical registries, which are required quality submissions that hospitals have to do. And we bring AI to the table so that we can make it a not-so-manual process. Historically, the way these forms have been completed has been with just nurse time. Also, I don't think there's a word in the English language to quite correctly describe form in this particular scenario. Just to give a concrete example, if a PCI, so a stent installation via cath is performed, it takes a nurse about an hour and a half to fill out the documentation required to do the submission to the registry. It takes a really long time." "The problem is that most of it is in the notes. So one of the questions in a registry was the patient hypertensive upon admission. And the way you figure that out is you look, in most cases, in the H&P note and read through it. It'll say somewhere in there that there's either a history of hypertension or they took a blood pressure, and now they have it, etc. And so, the nurse, to paint a picture about what this looks like here, what the nurse is doing is they have the EHR open on one screen, a form to fill out on the other, and they're reading through notes, reaching conclusions, and then filling out the form. So, most of the data needed for this whole process is in the clinical notes, not in some structured form." "Yes, so this is how we define quality in the whole shift to value-based care. A necessary component is that you measure quality in it. And this is just how the sausage is made for doing that. The way you measure something is you collect data for it. These registries are there to collect data, and in many cases, they are procedure-based. Sometimes, it's condition-based, like there's a COVID registry or what have you. Sometimes, it's a location-based thing like this patient was admitted to this unit like a CVICU or an acute care floor."  #CartaHealth #GenAI #HealthSystems #2024MedicalPredictions #HealthTech #MedTech CARTA.HEALTHCARE http://Carta.Healthcare DOWNLOAD THE TRANSCRIPT HERE http://Carta.Healthcare

18m

Mar 05

DR. DORON BEHAR, Co-Founder and CEO of Igentify, has a vision for the future of genetic counseling, where patients get the support they need to interpret and understand genetic screening results before the tests as well as after. With a shortage of genetic counselors, the solution, in part, lies in using technology to reduce waiting times and improve the interpretation of results while allowing the counselors to handle more patients effectively. The Igentify platform aims to support end-to-end services to provide precision medicine solutions to patients to meet specific needs and identify what test results might indicate about future health.   Doron explains, "We need to first speak about the genomic revolution and the crucial role of genetic counseling in it. So, as we know, we are all currently going through the genomic revolution, which means that we are anticipating that each of us will have genomic information, the full content of the genome, inside the medical record. The genetic counselors are the ones who are responsible for interpreting for us and explaining to us what our genome is telling us about our future health." "And particularly, the genome can identify potential risks that we might want to know about, whether it is related to reproductive health, cancer risk, or the use of drug pharmacogenomics. We can see literature saying that even recently, there were more than 5 million genetic tests sold in 2021. Less than 6,000 genetic counselors can present the information to the patients, and they are in North America. And if we compare to the world, there are only 7,500 genetic counselors globally." "The force model will allow us to use the digital genetic assistant and send information back to the patients, creating an end-to-end solution. Very importantly, we are using advanced and sophisticated multimedia content to approach the patients either in the pre- or in the post-test scenarios. These multimedia components allow speaking with the patients about their own situation. So maintaining a very high level of personalization, even speaking different languages to the patients, is particularly important, for example, to make sure that patients understand." #Igentify #GeneticCounseling #GeneticScreening #GeneticTesting #GeneticMedicine #DigitalHealth #PrecisionMedicine IGENTIFY.COM LISTEN TO THE PODCAST HERE http://igentify.com

1s

Mar 04

DR. DORON BEHAR, Co-Founder and CEO of Igentify, has a vision for the future of genetic counseling, where patients get the support they need to interpret and understand genetic screening results before the tests as well as after. With a shortage of genetic counselors, the solution, in part, lies in using technology to reduce waiting times and improve the interpretation of results while allowing the counselors to handle more patients effectively. The Igentify platform aims to support end-to-end services to provide precision medicine solutions to patients to meet specific needs and identify what test results might indicate about future health.   Doron explains, "We need to first speak about the genomic revolution and the crucial role of genetic counseling in it. So, as we know, we are all currently going through the genomic revolution, which means that we are anticipating that each of us will have genomic information, the full content of the genome, inside the medical record. The genetic counselors are the ones who are responsible for interpreting for us and explaining to us what our genome is telling us about our future health." "And particularly, the genome can identify potential risks that we might want to know about, whether it is related to reproductive health, cancer risk, or the use of drug pharmacogenomics. We can see literature saying that even recently, there were more than 5 million genetic tests sold in 2021. Less than 6,000 genetic counselors can present the information to the patients, and they are in North America. And if we compare to the world, there are only 7,500 genetic counselors globally." "The force model will allow us to use the digital genetic assistant and send information back to the patients, creating an end-to-end solution. Very importantly, we are using advanced and sophisticated multimedia content to approach the patients either in the pre- or in the post-test scenarios. These multimedia components allow speaking with the patients about their own situation. So maintaining a very high level of personalization, even speaking different languages to the patients, is particularly important, for example, to make sure that patients understand." #Igentify #GeneticCounseling #GeneticScreening #GeneticTesting #GeneticMedicine #DigitalHealth #PrecisionMedicine IGENTIFY.COM DOWNLOAD THE TRANSCRIPT HERE http://igentify.com

26m

Mar 04

DR. STEVEN CHEN, a breast surgeon and Chief Medical Officer at ImpediMed, discusses the early detection and treatment of lymphedema, a type of swelling that often occurs after breast cancer treatments.  Visual observation and measurements using a tape measure are the current, inaccurate methods of determining early warning signs. The ImpediMed SOZO device measures subtle changes in time for simple interventions such as wearing compression sleeves, now covered by Medicare, which can reverse the damage. Unaddressed, this condition can lead to severe functional problems.   Steven explains, "The whole goal of ImpediMed is to help people find this when it's in stage zero or stage one when it can be reversed. It's a very simple set of treatments when you catch it early, primarily wearing a sleeve, a compression sleeve, and/or a compression glove. And with that, you can reverse almost all the stage zeros and probably somewhere between 80% to 90% of stage ones. And so you can see that if you can catch it early, this will go away with a fairly simple set of treatments." "As you get into stage two and stage three, you're now talking about much more aggressive treatments - things like massage, pumps, and nighttime pumps to try to get the swelling down. And usually, that just provides temporary relief. It almost never goes all the way back to the way it was. Now, there are plastic surgeons and microsurgeons who have started doing things like transplanting lymph nodes to try to get more drainage. And that could be helpful as well. But again, it's rare once you get to stage two or three to see getting back to how you were before surgery." "In stage one, you can start to have measurement differences a little bit if you use a tape measure regularly. But as you might imagine, using a tape measure regularly takes time, but it's also somewhat hard to do. If you've ever tried to measure yourself with just a fabric tape measure, you do it two or three times in a row, and you might get two or three different measurements. So, trying to measure someone every three to six months and do it with precisely the same amount of tension is fairly difficult. But I think the real primary thing is people don't realize that this happens, and if it does happen, they can turn it around. So, patients don't complain to their doctors because they don't realize it's a consequence of their treatment."  #ImpediMed #Lymphedema #LymphedemaAwarenessMonth #LymphedemaPrevention #BreastCancerCare #BreastCancer #Survivorship IMPEDIMED.COM http://impediMed.com LISTEN TO THE PODCAST HERE img http://impediMed.com

1s

Feb 29

DR. STEVEN CHEN, a breast surgeon and Chief Medical Officer at ImpediMed, discusses the early detection and treatment of lymphedema, a type of swelling that often occurs after breast cancer treatments.  Visual observation and measurements using a tape measure are the current, inaccurate methods of determining early warning signs. The ImpediMed SOZO device measures subtle changes in time for simple interventions such as wearing compression sleeves, now covered by Medicare, which can reverse the damage. Unaddressed, this condition can lead to severe functional problems.   Steven explains, "The whole goal of ImpediMed is to help people find this when it's in stage zero or stage one when it can be reversed. It's a very simple set of treatments when you catch it early, primarily wearing a sleeve, a compression sleeve, and/or a compression glove. And with that, you can reverse almost all the stage zeros and probably somewhere between 80% to 90% of stage ones. And so you can see that if you can catch it early, this will go away with a fairly simple set of treatments." "As you get into stage two and stage three, you're now talking about much more aggressive treatments - things like massage, pumps, and nighttime pumps to try to get the swelling down. And usually, that just provides temporary relief. It almost never goes all the way back to the way it was. Now, there are plastic surgeons and microsurgeons who have started doing things like transplanting lymph nodes to try to get more drainage. And that could be helpful as well. But again, it's rare once you get to stage two or three to see getting back to how you were before surgery." "In stage one, you can start to have measurement differences a little bit if you use a tape measure regularly. But as you might imagine, using a tape measure regularly takes time, but it's also somewhat hard to do. If you've ever tried to measure yourself with just a fabric tape measure, you do it two or three times in a row, and you might get two or three different measurements. So, trying to measure someone every three to six months and do it with precisely the same amount of tension is fairly difficult. But I think the real primary thing is people don't realize that this happens, and if it does happen, they can turn it around. So, patients don't complain to their doctors because they don't realize it's a consequence of their treatment."  #ImpediMed #Lymphedema #LymphedemaAwarenessMonth #LymphedemaPrevention #BreastCancerCare #BreastCancer #Survivorship IMPEDIMED.COM http://impedimed.com DOWNLOAD THE TRANSCRIPT HERE img http://impediMed.com

19m

Feb 29

AMY BROWN, CEO of Authenticx, uses conversational intelligence to analyze conversations between humans and between humans and chatbots to gain insights that can drive improvements in patient experience, operational efficiency, and faster resolution of problems in the healthcare environment. Using AI and trained professionals, the Authenticx solution can help pharmaceutical companies improve drug launches, personalize customer interactions and respond more effectively to patient needs. In clinical situations, the machine learning models help identify and address obstacles impeding more robust patient/provider/payer relationships. Amy explains, "At Authenticx, we really target bidirectional conversations. We can take in all types of unstructured data that exist: notes, social, etc. That said, we find the most insightful and contextually rich types of data sources are the ones that represent a back-and-forth between customer and company. And in our world, we're working with very large healthcare companies, like pharmaceutical manufacturers, health insurance companies, health and hospital systems."  "They're typically having conversations with patients or caregivers, any type of healthcare consumer, they're also having conversations with other stakeholders in the healthcare system, like insurance companies talking to providers' offices, or doctors' offices talking to pharmaceutical manufacturers. We find that the research and study of that back-and-forth bidirectional communication, and doing that at scale, is incredibly insightful to the business." "We ingest the call recordings or the chat interaction files into our platform, and we apply AI to listen for the things that matter most to healthcare companies. We've spent five years curating our own proprietary training data, where we have listeners, human listeners, who have listened to hundreds of thousands of conversations. We intentionally hired social workers, healthcare workers, nurses, people who have worked inside the healthcare system, because we found that interpreting the communication they're listening to is so crucially important to making high-quality AI."  #Authenticx #ListeningWithAI #ConversationalIntelligence #PatientExperience #AIinHealthcare AUTHENTICX.COM http://Authenticx.com LISTEN TO THE PODCAST HERE img http://Authenticx.com

1s

Feb 28

AMY BROWN, CEO of Authenticx, uses conversational intelligence to analyze conversations between humans and between humans and chatbots to gain insights that can drive improvements in patient experience, operational efficiency, and faster resolution of problems in the healthcare environment. Using AI and trained professionals, the Authenticx solution helps pharmaceutical companies improve drug launches, personalize customer interactions and respond more effectively to patient needs. In clinical situations, the machine learning models help identify and address obstacles impeding more effective patient/provider/payer relationships. Amy explains, "At Authenticx, we really target bidirectional conversations. We can take in all types of unstructured data that exist: notes, social, etc. That said, we find the most insightful and contextually rich types of data sources are the ones that represent a back-and-forth between customer and company. And in our world, we're working with very large healthcare companies, like pharmaceutical manufacturers, health insurance companies, health and hospital systems."  "They're typically having conversations with patients or caregivers, any type of healthcare consumer, they're also having conversations with other stakeholders in the healthcare system, like insurance companies talking to providers' offices, or doctors' offices talking to pharmaceutical manufacturers. We find that the research and study of that back-and-forth bidirectional communication, and doing that at scale, is incredibly insightful to the business." "We ingest the call recordings or the chat interaction files into our platform, and we apply AI to listen for the things that matter most to healthcare companies. We've spent five years curating our own proprietary training data, where we have listeners, human listeners, who have listened to hundreds of thousands of conversations. We intentionally hired social workers, healthcare workers, nurses, people who have worked inside the healthcare system, because we found that interpreting the communication they're listening to is so crucially important to making high-quality AI."  #Authenticx #ListeningWithAI #ConversationalIntelligence #PatientExperience #AIinHealthcare AUTHENTICX.COM http://Authenticx.com DOWNLOAD THE TRANSCRIPT HERE img http://Authenticx.com

21m

Feb 28